Senior insider sale
Chief Financial Officer at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$3.75M
18.28K shares
What this filing means
ESPINOZA OCTAVIO plans to sell 18.28K shares of LIGAND PHARMACEUTICALS INC valued at approximately $3.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2026ACC: 0001950047-26-002496
Officer· Chief Financial Officer
Since Mar 2026
18.28K
Shares to sell
$3.75M
Approx. market value
3.06K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
3/11/2026
2.40KPreviously Exercised Stock Options
Cash
12/16/2025
652.00Total acquired3.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2026 | Exercise of Stock Options Cash | 2.40K | — |
12/16/2025 | Previously Exercised Stock Options Cash | 652.00 | — |
| Total | 3.06K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
13.42K
Market value
$2.76M
3/4/2026
—Completed
Units to sell
1.80K
Market value
$339.7K
12/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.06K
Market value
$649.0K
3/11/2026
Total
Units
18.28K
Value
$3.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 13.42K | $2.76M | — | Completed |
12/12/2025 | 1.80K | $339.7K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2026 | 3.06K | $649.0K | NASDAQ | Planned |
| Total | 18.28K | $3.75M | ||